Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer

Patients will be receive DC-CIK cell therapy at days 15, 17 and 19 per cycle and received cycles of treatment once every 21 days.

The dose of S-1 is determined according to the body surface area as follows: \<1.25 m2, 40 mg; 1.25 to \<1.5 m2, 50 mg; and ≥1.5 m2, 60 mg, given twice daily after meals for 14 days followed by 7 days rest.

Cisplatin is administered at 75 mg/m2 intravenously over 1 to 3 hours every 21 days.